Skip to main content
2024 CRT Conference Main banner
Back

CRT 2024

Coronary

Complex PCI

Session One [Non-CME]

Panel Discussion | Who Should Get MCS for High-Risk PCI and with Which Device?

Sunday, March 10, 2024
9:41 AM – 9:56 AM ET

    Panel Moderator(s)

  • David E. Kandzari, MD, FACC, FSCAI

    Director, Interventional Cardiology, Piedmont Heart Institute; Chief Scientific Officer, Piedmont Healthcare
    Piedmont Heart Institute
    Atlanta, Georgia, United States

    Disclosure information not submitted.

  • Jeffrey W. Moses, MD, FSCAI

    John and Myrna Daniels Professor of Cardiology
    Columbia University Medical Center
    New York, New York, United States

    Disclosure information not submitted.

    • Panel Discussant(s)

  • Debabrata Dash, MD, DM, FICC, FSCAI, FAPSC, FCCP, FACC, FESC

    Consultant Interventional Cardiologist
    Aster Hospital, Al Mankhool Dubai, UAE
    Dubai, Dubai, United Arab Emirates

    No relationships to disclose

  • Shaoliang Chen, MD

    Secretary
    Nanjing First Hospital,Nanjing Medical University
    Nanjing, Jiangsu, China (People's Republic)

    No relationships to disclose

  • Edo Kaluski, MD, FSCAI

    Director of Cath Lab & Interventional Cardiology
    Robert Packer Hospital Guthrie Health Systems
    Sayre, Pennsylvania, United States

    No relationships to disclose

  • Valeria Paradies, MD, MSc

    Interventional Cardiologist
    Maasstad Hospital, Rotterdam, The Netherlands
    Rotterdam, Netherlands

    No relationships to disclose

  • MP

    Manish A. Parikh, MD

    Chief of Cardiology
    The New York Presbyterian-Brooklyn Methodist Hospital
    New York, New York, United States

    No relationships to disclose

  • Tanveer Rab, MD, FACC, FSCAI

    Professor
    Emory University
    Decatur, Georgia, United States

    No relationships to disclose

  • JR

    Jennifer Rymer, MD

    Interventional cardiologist
    Duke, North Carolina, United States

    Disclosure(s): Abiomed Inc: Contracted Research (Ongoing); Chiesi Inc: Advisor (Ongoing), Contracted Research (Ongoing); idorsia pharmaceuticals: Clinical Trial Investigator (Ongoing); Novo Nordisk: Clinical Trial Investigator (Ongoing), Contracted Research (Ongoing)

  • Robert W. Yeh, MD, MSc

    Professor of Medicine
    Beth Israel Deaconess Medical Center
    Boston, Massachusetts, United States

    No relationships to disclose